Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtronic, St. Jude Ask CMS To Ease Restrictions On MRI-Cardio Trials

This article was originally published in The Gray Sheet

Executive Summary

Cardiac device makers Medtronic and St. Jude Medical want CMS to reconsider a proposal that would limit Medicare coverage of magnetic resonance imaging scans in patients with implanted heart devices to "ideal" clinical trials.

You may also be interested in...



Medtronic Revo MRI Pacer Approved, But Still Faces Reimbursement Hurdle

Medtronic is hoping that the immediate U.S. launch of its newly approved Revo MRI SureScan MRI-compatible pacemaker will help boost market share in the device category, but magnetic resonance imaging scans of implant recipients still face a key reimbursement hurdle.

Medtronic Revo MRI Pacer Approved, But Still Faces Reimbursement Hurdle

Medtronic is hoping that the immediate U.S. launch of its newly approved Revo MRI SureScan MRI-compatible pacemaker will help boost market share in the device category, but magnetic resonance imaging scans of implant recipients still face a key reimbursement hurdle.

CMS In Brief

Proposed rulemaking limits MRI coverage for pacemaker/defibrillator patients

Related Content

Topics

UsernamePublicRestriction

Register

MT029745

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel